{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:47:41Z","timestamp":1784735261597,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Fapesp","doi-asserted-by":"crossref","award":["2019\/10922-9"],"award-info":[{"award-number":["2019\/10922-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2022\/07471-8"],"award-info":[{"award-number":["2022\/07471-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12185-025-04099-6","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T16:56:42Z","timestamp":1762966602000},"page":"9-23","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advancements in gene therapy for Wiskott\u2013Aldrich syndrome: from early trials to emerging approaches"],"prefix":"10.1007","volume":"123","author":[{"given":"Luana","family":"de Mambro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0653-5968","authenticated-orcid":false,"given":"Roberta Sessa","family":"Stilhano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"1","key":"4099_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/nyas.12049","volume":"1285","author":"MJ Massaad","year":"2013","unstructured":"Massaad MJ, Ramesh N, Geha RS. Wiskott-aldrich syndrome: a comprehensive review. Ann N Y Acad Sci. 2013;1285(1):26\u201343.","journal-title":"Ann N Y Acad Sci"},{"issue":"25","key":"4099_CR2","doi-asserted-by":"publisher","first-page":"6288","DOI":"10.1182\/blood-2008-12-115253","volume":"113","author":"M Bosticardo","year":"2009","unstructured":"Bosticardo M, Marangoni F, Aiuti A, Villa A, Grazia RM. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood. 2009;113(25):6288\u201395.","journal-title":"Blood"},{"key":"4099_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/TACG.S58444","volume":"7","author":"D Buchbinder","year":"2014","unstructured":"Buchbinder D, Nugent DJ, Fillipovich AH. Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments. Appl Clin Genet. 2014;7:55\u201366.","journal-title":"Appl Clin Genet"},{"issue":"6148","key":"4099_CR4","doi-asserted-by":"publisher","first-page":"1233151","DOI":"10.1126\/science.1233151","volume":"341","author":"A Aiuti","year":"2013","unstructured":"Aiuti A, Biasco L, Scaramuzza S, Ferrua F, Cicalese MP, Baricordi C, et al. Lentivirus-based gene therapy of hematopoietic stem cells in Wiskott-Aldrich Syndrome. Science. 2013;341(6148):1233151.","journal-title":"Science."},{"issue":"2","key":"4099_CR5","doi-asserted-by":"publisher","first-page":"101247","DOI":"10.1016\/j.omtm.2024.101247","volume":"32","author":"A Naseem","year":"2024","unstructured":"Naseem A, Cavazza A. It\u2019s all about location: targeting the right spot for Wiskott-Aldrich syndrome. Mol Ther Methods Clin Dev. 2024;32(2):101247.","journal-title":"Mol Ther Methods Clin Dev."},{"issue":"13","key":"4099_CR6","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1182\/blood-2003-05-1592","volume":"104","author":"Y Jin","year":"2004","unstructured":"Jin Y, Mazza C, Christie JR, Giliani S, Fiorini M, Mella P, et al. Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype\/genotype correlation. Blood. 2004;104(13):4010\u20139.","journal-title":"Blood."},{"issue":"1","key":"4099_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/ped.12819","volume":"58","author":"Y Sasahara","year":"2016","unstructured":"Sasahara Y. WASP\u2013WIP complex in the molecular pathogenesis of Wiskott-Aldrich syndrome. Pediatr Int. 2016;58(1):4\u20137.","journal-title":"Pediatr Int"},{"issue":"12","key":"4099_CR8","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1182\/blood-2004-04-1678","volume":"104","author":"S Burns","year":"2004","unstructured":"Burns S, Cory GO, Vainchenker W, Thrasher AJ. Mechanisms of WASp-mediated hematologic and immunologic disease. Blood. 2004;104(12):3454\u201362.","journal-title":"Blood"},{"issue":"1","key":"4099_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0962-8924(98)01411-1","volume":"9","author":"N Ramesh","year":"1999","unstructured":"Ramesh N, Ant\u00f3n IM, Martinez Quiles N, Geha RS. Waltzing with WASP. Trends Cell Biol. 1999;9(1):15\u20139.","journal-title":"Trends Cell Biol."},{"issue":"11","key":"4099_CR10","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1002\/eji.201646715","volume":"47","author":"E Rivers","year":"2017","unstructured":"Rivers E, Thrasher AJ. Wiskott-Aldrich syndrome protein: emerging mechanisms in immunity. Eur J Immunol. 2017;47(11):1857\u201366.","journal-title":"Eur J Immunol."},{"key":"4099_CR11","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.2147\/JMDH.S295386","volume":"14","author":"S Hosahalli Vasanna","year":"2021","unstructured":"Hosahalli Vasanna S, Pereda MA, Dalal J. Clinical features, cancer biology, transplant approach and other integrated management strategies for Wiskott-Aldrich syndrome. J Multidiscip Healthc. 2021;14:3497\u2013512.","journal-title":"J Multidiscip Healthc"},{"issue":"24","key":"4099_CR12","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1182\/blood.2023021411","volume":"143","author":"TC Vall\u00e9e","year":"2024","unstructured":"Vall\u00e9e TC, Glasmacher JS, Buchner H, Arkwright PD, Behrends U, Bondarenko A, et al. Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survival. Blood. 2024;143(24):2504\u201316.","journal-title":"Blood"},{"key":"4099_CR13","doi-asserted-by":"publisher","first-page":"627651","DOI":"10.3389\/fimmu.2021.627651","volume":"12","author":"D Suri","year":"2021","unstructured":"Suri D, Rikhi R, Jindal AK, Rawat A, Sudhakar M, Vignesh P, et al. Wiskott aldrich syndrome: a multi-institutional experience from India. Front Immunol. 2021;12:627651.","journal-title":"Front Immunol."},{"key":"4099_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2147\/TACG.S213920","volume":"14","author":"M Sudhakar","year":"2021","unstructured":"Sudhakar M, Rikhi R, Loganathan SK, Suri D, Singh S. Autoimmunity in Wiskott-aldrich syndrome: updated perspectives. Appl Clin Genet. 2021;14:363\u201388.","journal-title":"Appl Clin Genet."},{"issue":"1 Suppl","key":"4099_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bbmt.2008.10.007","volume":"15","author":"HD Ochs","year":"2009","unstructured":"Ochs HD, Filipovich AH, Veys P, Cowan MJ, Kapoor N. Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment. Biol Blood Marrow Transplant janeiro de. 2009;15(1 Suppl):84\u201390.","journal-title":"Biol Blood Marrow Transplant janeiro de"},{"key":"4099_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fimmu.2012.00209","volume":"3","author":"M Catucci","year":"2012","unstructured":"Catucci M, Castiello MC, Pala F, Bosticardo M, Villa A. Autoimmunity in Wiskott-Aldrich syndrome: an unsolved enigma. Front Immunol. 2012;3:209.","journal-title":"Front Immunol"},{"key":"4099_CR17","doi-asserted-by":"publisher","first-page":"1229674","DOI":"10.3389\/fimmu.2023.1229674","volume":"14","author":"E Coppola","year":"2023","unstructured":"Coppola E, Giardino G, Abate M, Tambaro FP, Bifano D, Toriello E, et al. Rare solid tumors in a patient with Wiskott-Aldrich syndrome after hematopoietic stem cell transplantation: case report and review of literature. Front Immunol. 2023;14:1229674.","journal-title":"Front Immunol."},{"issue":"5","key":"4099_CR18","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.1542\/peds.111.5.e622","volume":"111","author":"S Dupuis-Girod","year":"2003","unstructured":"Dupuis-Girod S, Medioni J, Haddad E, Quartier P, Cavazzana-Calvo M, Le Deist F, et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics. 2003;111(5):e622-7.","journal-title":"Pediatrics"},{"issue":"6","key":"4099_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/1744666X.2022.2074400","volume":"18","author":"C Cavannaugh","year":"2022","unstructured":"Cavannaugh C, Ochs HD, Buchbinder D. Diagnosis and clinical management of Wiskott-Aldrich syndrome: current and emerging techniques. Exp Rev Clin Immunol. 2022;18(6):609\u201323.","journal-title":"Exp Rev Clin Immunol"},{"issue":"5","key":"4099_CR20","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s11882-001-0028-0","volume":"1","author":"S Nonoyama","year":"2001","unstructured":"Nonoyama S, Ochs HD. Wiskott-aldrich syndrome. Curr Allergy Asthma Rep. 2001;1(5):430\u20137.","journal-title":"Curr Allergy Asthma Rep."},{"issue":"6","key":"4099_CR21","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1182\/blood-2010-11-319376","volume":"118","author":"D Moratto","year":"2011","unstructured":"Moratto D, Giliani S, Bonfim C, Mazzolari E, Fischer A, Ochs HD, et al. Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980\u20132009: an international collaborative study. Blood. 2011;118(6):1675\u201384.","journal-title":"Blood."},{"issue":"2","key":"4099_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neulet.2012.04.078","volume":"527","author":"JR Mendell","year":"2012","unstructured":"Mendell JR, Rodino-Klapac L, Sahenk Z, Malik V, Kaspar BK, Walker CM, et al. Gene Therapy for muscular dystrophy: lessons learned and path forward. Neurosci Lett. 2012;527(2):90\u20139.","journal-title":"Neurosci Lett."},{"issue":"5","key":"4099_CR23","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.ymthe.2017.03.024","volume":"25","author":"M Cavazzana","year":"2017","unstructured":"Cavazzana M, Antoniani C, Miccio A. Gene therapy for \u03b2-hemoglobinopathies. Mol Ther. 2017;25(5):1142\u201354.","journal-title":"Mol Ther"},{"issue":"1","key":"4099_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11010-020-03834-3","volume":"474","author":"R Tang","year":"2020","unstructured":"Tang R, Xu Z. Gene therapy: a double-edged sword with great powers. Mol Cell Biochem. 2020;474(1):73\u201381.","journal-title":"Mol Cell Biochem."},{"issue":"2","key":"4099_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1517\/14712598.8.2.181","volume":"8","author":"A Galy","year":"2008","unstructured":"Galy A, Roncarolo MG, Thrasher AJ. Development of lentiviral gene therapy for Wiskott Aldrich syndrome. Expert Opin Biol Ther fevereiro de. 2008;8(2):181\u201390.","journal-title":"Expert Opin Biol Ther fevereiro de"},{"issue":"2","key":"4099_CR26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jaci.2020.06.018","volume":"146","author":"F Ferrua","year":"2020","unstructured":"Ferrua F, Marangoni F, Aiuti A, Roncarolo MG. Gene therapy for Wiskott-Aldrich syndrome: History, new vectors, future directions. J Allergy Clin Immunol agosto de. 2020;146(2):262\u20135.","journal-title":"J Allergy Clin Immunol agosto de"},{"issue":"5","key":"4099_CR27","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1016\/S2352-3026(19)30021-3","volume":"6","author":"F Ferrua","year":"2019","unstructured":"Ferrua F, Cicalese MP, Galimberti S, Giannelli S, Dionisio F, Barzaghi F, et al. Lentiviral haemopoietic stem\/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1\/2 clinical study. Lancet Haematol maio de. 2019;6(5):e239\u201353.","journal-title":"Lancet Haematol maio de"},{"issue":"9","key":"4099_CR28","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/sj.gt.3301950","volume":"10","author":"TS Strom","year":"2003","unstructured":"Strom TS, Gabbard W, Kelly PF, Cunningham JM, Nienhuis AW. Functional correction of T cells derived from patients with the Wiskott-Aldrich syndrome (WAS) by transduction with an oncoretroviral vector encoding the WAS protein. Gene Ther maio de. 2003;10(9):803\u20139.","journal-title":"Gene Ther maio de"},{"issue":"2","key":"4099_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1074-7613(02)00360-6","volume":"17","author":"L Dupr\u00e9","year":"2002","unstructured":"Dupr\u00e9 L, Aiuti A, Trifari S, Martino S, Saracco P, Bordignon C, et al. Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity. 2002;17(2):157\u201366.","journal-title":"Immunity."},{"issue":"9","key":"4099_CR30","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1089\/104303402753812449","volume":"13","author":"T Wada","year":"2002","unstructured":"Wada T, Jagadeesh GJ, Nelson DL, Candotti F. Retrovirus-mediated WASP gene transfer corrects Wiskott-Aldrich syndrome T-cell dysfunction. Human Gene Therapy. 2002;13(9):1039\u201346.","journal-title":"Human Gene Therapy"},{"issue":"20","key":"4099_CR31","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1056\/NEJMoa1003548","volume":"363","author":"K Boztug","year":"2010","unstructured":"Boztug K, Schmidt M, Schwarzer A, Banerjee PP, D\u00edez IA, Dewey RA, et al. Stem-cell gene therapy for the Wiskott-Aldrich syndrome. New England J Med. 2010;363(20):1918\u201327.","journal-title":"New England J Med"},{"issue":"227","key":"4099_CR32","doi-asserted-by":"publisher","first-page":"22733","DOI":"10.1126\/scitranslmed.3007280","volume":"6","author":"CJ Braun","year":"2014","unstructured":"Braun CJ, Boztug K, Paruzynski A, Witzel M, Schwarzer A, Rothe M, et al. Gene therapy for wiskott-aldrich syndrome\u2014long-term efficacy and genotoxicity. Sci Trans Med. 2014;6(227):22733.","journal-title":"Sci Trans Med."},{"issue":"6","key":"4099_CR33","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/mt.2012.93","volume":"20","author":"J Corrigan-Curay","year":"2012","unstructured":"Corrigan-Curay J, Cohen-Haguenauer O, O\u2019Reilly M, Ross SR, Fan H, Rosenberg N, et al. Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy. Mol Ther junho de. 2012;20(6):1084\u201394.","journal-title":"Mol Ther junho de"},{"issue":"12","key":"4099_CR34","doi-asserted-by":"publisher","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","volume":"72","author":"R Zufferey","year":"1998","unstructured":"Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol dezembro de. 1998;72(12):9873\u201380.","journal-title":"J Virol dezembro de"},{"issue":"7","key":"4099_CR35","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","volume":"32","author":"MC Milone","year":"2018","unstructured":"Milone MC, O\u2019Doherty U. Clinical use of lentiviral vectors. Leukemia julho de. 2018;32(7):1529\u201341.","journal-title":"Leukemia julho de"},{"issue":"6","key":"4099_CR36","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ymthe.2005.01.005","volume":"11","author":"G Mostoslavsky","year":"2005","unstructured":"Mostoslavsky G, Kotton DN, Fabian AJ, Gray JT, Lee JS, Mulligan RC. Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation. Mol Ther. 2005;11(6):932\u201340.","journal-title":"Mol Ther."},{"issue":"20","key":"4099_CR37","doi-asserted-by":"publisher","first-page":"11939","DOI":"10.1073\/pnas.95.20.11939","volume":"95","author":"N Uchida","year":"1998","unstructured":"Uchida N, Sutton RE, Friera AM, He D, Reitsma MJ, Chang WC, et al. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0\/G1 human hematopoietic stem cells. Proceed Nat Acad Sci. 1998;95(20):11939\u201344.","journal-title":"Proceed Nat Acad Sci."},{"issue":"5","key":"4099_CR38","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/sj.gt.3302863","volume":"14","author":"S Charrier","year":"2007","unstructured":"Charrier S, Dupr\u00e9 L, Scaramuzza S, Jeanson-Leh L, Blundell MP, Danos O, et al. Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients. Gene Ther mar\u00e7o de. 2007;14(5):415\u201328.","journal-title":"Gene Ther mar\u00e7o de"},{"issue":"3","key":"4099_CR39","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1089\/hum.2006.17.303","volume":"17","author":"L Dupr\u00e9","year":"2006","unstructured":"Dupr\u00e9 L, Marangoni F, Scaramuzza S, Trifari S, Hern\u00e1ndez RJ, Aiuti A, et al. Efficacy of Gene Therapy for Wiskott-Aldrich Syndrome Using a WAS Promoter\/cDNA-Containing Lentiviral Vector and Nonlethal Irradiation. Human Gene Therapy mar\u00e7o de. 2006;17(3):303\u201313.","journal-title":"Human Gene Therapy mar\u00e7o de"},{"issue":"5","key":"4099_CR40","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.ymthe.2004.08.008","volume":"10","author":"L Dupr\u00e9","year":"2004","unstructured":"Dupr\u00e9 L, Trifari S, Follenzi A, Marangoni F, de Lera TL, Bernad A, et al. Lentiviral vector-mediated gene transfer in T Cells from Wiskott-Aldrich syndrome patients leads to functional correction. Mol Ther. 2004;10(5):903\u201315.","journal-title":"Mol Ther."},{"issue":"1","key":"4099_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41591-021-01641-x","volume":"28","author":"A Magnani","year":"2022","unstructured":"Magnani A, Semeraro M, Adam F, Booth C, Dupr\u00e9 L, Morris EC, et al. Long-term safety and efficacy of lentiviral hematopoietic stem\/progenitor cell gene therapy for Wiskott-Aldrich syndrome. Nat Med janeiro de. 2022;28(1):71\u201380.","journal-title":"Nat Med janeiro de"},{"key":"4099_CR42","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1038\/s41467-023-38448-y","volume":"14","author":"S Scala","year":"2023","unstructured":"Scala S, Ferrua F, Basso-Ricci L, Dionisio F, Omrani M, Quaranta P, et al. Hematopoietic reconstitution dynamics of mobilized- and bone marrow-derived human hematopoietic stem cells after gene therapy. Nat Commun. 2023;14:3068.","journal-title":"Nat Commun."},{"key":"4099_CR43","doi-asserted-by":"publisher","first-page":"966084","DOI":"10.3389\/fimmu.2022.966084","volume":"13","author":"A Naseem","year":"2022","unstructured":"Naseem A, Steinberg Z, Cavazza A. Genome editing for primary immunodeficiencies: a therapeutic perspective on Wiskott-Aldrich syndrome. Front Immunol. 2022;13:966084.","journal-title":"Front Immunol"},{"issue":"372","key":"4099_CR44","doi-asserted-by":"publisher","first-page":"eaah3480","DOI":"10.1126\/scitranslmed.aah3480","volume":"9","author":"SS De Ravin","year":"2017","unstructured":"De Ravin SS, Li L, Wu X, Choi U, Allen C, Koontz S, et al. CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease. Sci Trans Med. 2017;9(372):eaah3480.","journal-title":"Sci Trans Med"},{"issue":"1","key":"4099_CR45","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13287-024-03848-4","volume":"15","author":"Z Molaei","year":"2024","unstructured":"Molaei Z, Jabbarpour Z, Omidkhoda A, Ahmadbeigi N. Exploring non-viral methods for the delivery of CRISPR-Cas ribonucleoprotein to hematopoietic stem cells. Stem Cell Res Ther. 2024;15(1):233.","journal-title":"Stem Cell Res Ther."},{"key":"4099_CR46","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/s41467-019-09614-y","volume":"10","author":"M Pavel-Dinu","year":"2019","unstructured":"Pavel-Dinu M, Wiebking V, Dejene BT, Srifa W, Mantri S, Nicolas CE, et al. Gene correction for SCID-X1 in long-term hematopoietic stem cells. Nat Commun. 2019;10:1634.","journal-title":"Nat Commun."},{"issue":"1","key":"4099_CR47","doi-asserted-by":"publisher","first-page":"101208","DOI":"10.1016\/j.omtm.2024.101208","volume":"32","author":"M Pille","year":"2024","unstructured":"Pille M, Avila JM, Park SH, Le CQ, Xue H, Haerynck F, et al. Gene editing-based targeted integration for correction of Wiskott-Aldrich syndrome. Mol Ther Methods Clin Dev. 2024;32(1):101208.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"4099_CR48","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.1038\/s41467-020-17626-2","volume":"11","author":"R Rai","year":"2020","unstructured":"Rai R, Romito M, Rivers E, Turchiano G, Blattner G, Vetharoy W, et al. Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott -\u00a0Aldrich Syndrome. Nat Commun. 2020;11:4034.","journal-title":"Nat Commun."},{"issue":"9","key":"4099_CR49","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/nrg2842","volume":"11","author":"FD Urnov","year":"2010","unstructured":"Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD. Genome editing with engineered zinc finger nucleases. Nat Rev Genet setembro de. 2010;11(9):636\u201346.","journal-title":"Nat Rev Genet setembro de"},{"issue":"2","key":"4099_CR50","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.stemcr.2016.06.003","volume":"7","author":"TJ Laskowski","year":"2016","unstructured":"Laskowski TJ, Van Caeneghem Y, Pourebrahim R, Ma C, Ni Z, Garate Z, et al. Gene correction of iPSCs from a Wiskott-Aldrich Syndrome patient normalizes the lymphoid developmental and functional defects. Stem Cell Reports. 2016;7(2):139\u201348.","journal-title":"Stem Cell Reports."},{"issue":"3","key":"4099_CR51","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1089\/hum.2017.047","volume":"29","author":"A Gutierrez-Guerrero","year":"2018","unstructured":"Gutierrez-Guerrero A, Sanchez-Hernandez S, Galvani G, Pinedo-Gomez J, Martin-Guerra R, Sanchez-Gilabert A, et al. Comparison of Zinc Finger Nucleases Versus CRISPR-Specific Nucleases for genome editing of the Wiskott-Aldrich Syndrome Locus. Hum Gene Ther mar\u00e7o de. 2018;29(3):366\u201380.","journal-title":"Hum Gene Ther mar\u00e7o de"},{"issue":"9","key":"4099_CR52","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.3390\/ijms26094067","volume":"26","author":"S Haider","year":"2025","unstructured":"Haider S, Mussolino C. Fine-tuning homology-directed repair (hdr) for precision genome editing: current strategies and future directions. Int J Mol Sci. 2025;26(9):4067.","journal-title":"Int J Mol Sci."},{"key":"4099_CR53","doi-asserted-by":"publisher","first-page":"966084","DOI":"10.3389\/fimmu.2022.966084","volume":"13","author":"A Naseem","year":"2022","unstructured":"Naseem A, Steinberg Z, Cavazza A. Genome editing for primary immunodeficiencies: a therapeutic perspective on Wiskott-aldrich syndrome. Front Immunol. 2022;13:966084.","journal-title":"Front Immunol."},{"issue":"9","key":"4099_CR54","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/nbt.3290","volume":"33","author":"A Hendel","year":"2015","unstructured":"Hendel A, Bak RO, Clark JT, Kennedy AB, Ryan DE, Roy S, et al. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nat Biotechnol setembro de. 2015;33(9):985\u20139.","journal-title":"Nat Biotechnol setembro de"},{"issue":"1","key":"4099_CR55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nbt.3081","volume":"33","author":"JA Zuris","year":"2015","unstructured":"Zuris JA, Thompson DB, Shu Y, Guilinger JP, Bessen JL, Hu JH, et al. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat Biotechnol janeiro de. 2015;33(1):73\u201380.","journal-title":"Nat Biotechnol janeiro de"},{"issue":"11","key":"4099_CR56","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc novembro de. 2013;8(11):2281\u2013308.","journal-title":"Nat Protoc novembro de"},{"key":"4099_CR57","doi-asserted-by":"publisher","first-page":"1148650","DOI":"10.3389\/fgeed.2023.1148650","volume":"5","author":"JH Wolff","year":"2023","unstructured":"Wolff JH, Mikkelsen JG. Prime editing in hematopoietic stem cells\u2014From ex vivo to in vivo CRISPR-based treatment of blood disorders. Front Genome Ed. 2023;5:1148650.","journal-title":"Front Genome Ed."},{"issue":"12","key":"4099_CR58","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","volume":"19","author":"HA Rees","year":"2018","unstructured":"Rees HA, Liu DR. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat Rev Genet dezembro de. 2018;19(12):770\u201388.","journal-title":"Nat Rev Genet dezembro de"},{"issue":"6","key":"4099_CR59","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41587-023-01915-4","volume":"42","author":"M Fiumara","year":"2024","unstructured":"Fiumara M, Ferrari S, Omer-Javed A, Beretta S, Albano L, Canarutto D, et al. Genotoxic effects of base and prime editing in human hematopoietic stem cells. Nat Biotechnol. 2024;42(6):877\u201391.","journal-title":"Nat Biotechnol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04099-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-04099-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04099-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:02:54Z","timestamp":1768834974000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-04099-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4099"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-04099-6","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"13 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This review article is based on previously published studies and does not involve any new studies with human participants or animals conducted by the authors. As such, ethical approval and consent to participate were not required for this work. All the sources referenced have been appropriately cited to acknowledge the original authors and their contributions to the field.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}